Table 3 Phase-III studies dedicated to elderly patients with advanced non-small cell lung cancer
Author (Year)DrugsPatients nResponse rate %Median survival months1-year survival rate %p-value
Elvis (1999)VNR7619.76.5320.03
BSC8519.74.914
Frasci (2000)VNR6022713<0.01
Gem + VNR60154.530
Gridelli (2003)VNR218.542ns
Gem700166.528
Gem + VNR18.17.434
Kudoh (2006)VNR1829.99.9NRns
Doc18222.714NR
Tsukada (2007)Doc Carbo + Doc63
Quoix (2011)VNR or Gem226106.225.40.0004
Carbo + weekly Pacli2252710.344.5